Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) have earned an average rating of “Moderate Buy” from the fifteen research firms that are presently covering the company, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation and twelve have issued a buy recommendation on the company. The average 1 […]
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR – Free Report) – Research analysts at Brookline Capital Management lowered their Q3 2024 earnings per share (EPS) estimates for X4 Pharmaceuticals in a note issued to investors on Monday, April 29th. Brookline Capital Management analyst L. Cann now expects that the company will post earnings per share of ($0.19) for […]
14,726 Shares in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Purchased by Mach 1 Financial Group LLC theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
ACADIA Pharmaceuticals (NASDAQ:ACAD – Get Free Report)‘s stock had its “overweight” rating reaffirmed by research analysts at Cantor Fitzgerald in a report released on Tuesday, Benzinga reports. They presently have a $37.00 price target on the biopharmaceutical company’s stock. Cantor Fitzgerald’s price objective would indicate a potential upside of 118.16% from the company’s current price. […]
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Get Free Report) insider Sarina Tanimoto sold 100,000 shares of the company’s stock in a transaction dated Tuesday, April 16th. The shares were sold at an average price of $9.28, for a total transaction of $928,000.00. Following the completion of the transaction, the insider now directly owns 1,647,447 shares in […]